Report cover image

Global Equine Healthcare Market Size study, by Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services and Others), Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equ

Publisher Bizwit Research & Consulting
Published May 10, 2025
Length 285 Pages
SKU # BIZW20037567

Description

Global Equine Healthcare Market is valued approximately at USD 2.44 billion in 2023 and is anticipated to grow with an impressive compound annual growth rate of more than 6.30% over the forecast period 2024–2032. In the rapidly evolving domain of animal health, equine healthcare has secured a pivotal role as owners, trainers, and veterinarians increasingly prioritize specialized and preventive care for horses. The rising awareness surrounding equine diseases, the economic significance of the equestrian industry, and the increasing longevity of horses have synergized to fuel the demand for structured, technology-integrated healthcare solutions. From high-end biologics and precision diagnostics to cloud-based herd management platforms, the market is witnessing an unprecedented convergence of veterinary science and digital innovation.

A primary force driving this transformation is the growing participation in equestrian sports and recreational horse ownership across both developed and emerging regions. Competitive performance expectations and the emotional bond between owners and animals are contributing to greater expenditures on vaccines, parasite control, and musculoskeletal disorder management. Additionally, emerging diseases like West Nile Virus and Equine Influenza are heightening the demand for continuous surveillance, early diagnostics, and rapid-response therapeutic options. Market players are increasingly introducing medicinal feed additives and personalized nutrition regimens, enhancing immunity and supporting recovery in athletic and aging horses alike.

However, challenges persist in the form of high procedural costs, limited accessibility in remote areas, and uneven distribution of veterinary infrastructure. Regulatory hurdles concerning biological product approvals and a scarcity of equine-specific veterinary specialists also pose hurdles to scaling up. Moreover, digital adoption remains uneven, with smaller veterinary facilities often lagging in technological transformation. Nonetheless, the integration of wearable monitoring devices, equine telemedicine, and advanced imaging solutions is slowly closing the gap, driving efficiency and clinical precision in long-term care.

In tandem, the shift toward online veterinary platforms and subscription-based medication delivery is revolutionizing distribution. E-commerce is becoming a vital channel for procuring equine pharmaceuticals and diagnostic tools, especially in North America and Europe. Global health authorities and veterinary schools are collaborating to raise disease awareness and train equine professionals through continuous education, fostering a more informed consumer and practitioner base. Meanwhile, data-driven equine welfare programs and genetic screening are gaining ground, empowering horse owners to make informed decisions about breeding, training, and therapy.

Regionally, North America led the global equine healthcare market in 2023, buoyed by strong institutional veterinary networks, high equine sports activity, and a technologically advanced ecosystem. Europe is a close contender, with stringent equine welfare regulations and sophisticated insurance models further fueling adoption. Asia Pacific is poised for rapid growth, especially in markets like Australia, India, and China where equine participation in sports, agriculture, and ceremonial functions is increasing. Latin America and the Middle East & Africa, though currently niche markets, are beginning to emerge as growth frontiers owing to government-led equine health initiatives and expanding veterinary outreach.

Major market player included in this report are:
• Merck & Co., Inc.
• Vetoquinol S.A.
• Ceva Santé Animale
• Dechra Pharmaceuticals PLC
• Boehringer Ingelheim International GmbH
• Zoetis Inc.
• Bayer AG
• Elanco Animal Health Inc.
• Virbac
• Norbrook Laboratories Ltd.
• Hallmarq Veterinary Imaging Ltd.
• Neogen Corporation
• Bimeda Animal Health
• Equine Products UK Ltd.
• IDEXX Laboratories, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product
• Vaccines
• Pharmaceuticals
• Medicinal Feed Additives
• Diagnostics
• Software & Services
• Others

By Indication
• Musculoskeletal Disorders
• Parasite Control
• Internal Medicine
• Equine Herpes Virus
• Equine Encephalomyelitis
• Equine Influenza
• West Nile Virus
• Tetanus
• Others

By Activity
• Sports/Racing
• Recreation
• Others

By Distribution Channel
• Veterinary Hospitals & Clinics
• E-commerce
• Others

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:
• Historical Year – 2022
• Base Year – 2023
• Forecast Period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Equine Healthcare Market Executive Summary
1.1. Global Equine Healthcare Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Indication
1.3.3. By Activity
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Equine Healthcare Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Owner & Practitioner Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Stakeholder Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Equine Healthcare Market Dynamics
3.1. Market Drivers
3.1.1. Growth of Equestrian Sports and Recreational Ownership
3.1.2. Rising Prevalence of Equine Infectious Diseases
3.1.3. Adoption of Precision Diagnostics and Biologics
3.2. Market Challenges
3.2.1. High Cost of Specialized Equine Treatments
3.2.2. Inequitable Access to Veterinary Infrastructure
3.2.3. Regulatory Hurdles for Biological Approvals
3.3. Market Opportunities
3.3.1. E-commerce and Subscription Delivery Models
3.3.2. Wearable Monitoring and Telemedicine Integration
3.3.3. Data-Driven Genetic and Welfare Programs
Chapter 4. Global Equine Healthcare Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Model
4.1.7. Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Equine Healthcare Market Size & Forecasts by Product, 2022–2032
5.1. Segment Dashboard
5.2. By Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Vaccines
5.2.2. Pharmaceuticals
5.2.3. Medicinal Feed Additives
5.2.4. Diagnostics
5.2.5. Software & Services
5.2.6. Others
Chapter 6. Global Equine Healthcare Market Size & Forecasts by Indication, 2022–2032
6.1. Segment Dashboard
6.2. By Indication Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Musculoskeletal Disorders
6.2.2. Parasite Control
6.2.3. Internal Medicine
6.2.4. Equine Herpes Virus
6.2.5. Equine Encephalomyelitis
6.2.6. Equine Influenza
6.2.7. West Nile Virus
6.2.8. Tetanus
6.2.9. Others
Chapter 7. Global Equine Healthcare Market Size & Forecasts by Activity, 2022–2032
7.1. Segment Dashboard
7.2. By Activity Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. Sports/Racing
7.2.2. Recreation
7.2.3. Others
Chapter 8. Global Equine Healthcare Market Size & Forecasts by Distribution Channel, 2022–2032
8.1. Segment Dashboard
8.2. By Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
8.2.1. Veterinary Hospitals & Clinics
8.2.2. E-commerce
8.2.3. Others
Chapter 9. Global Equine Healthcare Market Size & Forecasts by Region, 2022–2032
9.1. North America Market
9.1.1. U.S. Market
9.1.2. Canada Market
9.2. Europe Market
9.2.1. UK Market
9.2.2. Germany Market
9.2.3. France Market
9.2.4. Spain Market
9.2.5. Italy Market
9.2.6. Rest of Europe Market
9.3. Asia Pacific Market
9.3.1. China Market
9.3.2. India Market
9.3.3. Japan Market
9.3.4. Australia Market
9.3.5. South Korea Market
9.3.6. Rest of Asia Pacific Market
9.4. Latin America Market
9.4.1. Brazil Market
9.4.2. Mexico Market
9.5. Middle East & Africa Market
9.5.1. Saudi Arabia Market
9.5.2. South Africa Market
9.5.3. Rest of Middle East & Africa Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Merck & Co., Inc.
10.1.2. Vetoquinol S.A.
10.1.3. Ceva Santé Animale
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Merck & Co., Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Vetoquinol S.A.
10.3.3. Ceva Santé Animale
10.3.4. Dechra Pharmaceuticals PLC
10.3.5. Boehringer Ingelheim International GmbH
10.3.6. Zoetis Inc.
10.3.7. Bayer AG
10.3.8. Elanco Animal Health Inc.
10.3.9. Virbac
10.3.10. Norbrook Laboratories Ltd.
10.3.11. Hallmarq Veterinary Imaging Ltd.
10.3.12. Neogen Corporation
10.3.13. Bimeda Animal Health
10.3.14. Equine Products UK Ltd.
10.3.15. IDEXX Laboratories, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
TABLE 1. Global Equine Healthcare market report scope
TABLE 2. Global Equine Healthcare market estimates & forecasts by Region, 2022–2032 (USD Million/Billion)
TABLE 3. Global Equine Healthcare market estimates & forecasts by Product, 2022–2032
TABLE 4. Global Equine Healthcare market estimates & forecasts by Indication, 2022–2032
TABLE 5. Global Equine Healthcare market estimates & forecasts by Activity, 2022–2032
TABLE 6. Global Equine Healthcare market estimates & forecasts by Distribution Channel, 2022–2032
TABLE 7. North America Equine Healthcare market estimates & forecasts, 2022–2032
TABLE 8. U.S. Equine Healthcare market estimates & forecasts by segment, 2022–2032
TABLE 9. Canada Equine Healthcare market estimates & forecasts by segment, 2022–2032
TABLE 10. Europe Equine Healthcare market estimates & forecasts, 2022–2032
TABLE 11. UK Equine Healthcare market estimates & forecasts by segment, 2022–2032
TABLE 12. Asia Pacific Equine Healthcare market estimates & forecasts, 2022–2032
TABLE 13. Latin America Equine Healthcare market estimates & forecasts, 2022–2032
TABLE 14. Brazil Equine Healthcare market estimates & forecasts by segment, 2022–2032
TABLE 15. Middle East & Africa Equine Healthcare market estimates & forecasts, 2022–2032
TABLE 16. Competitive structure and company market share (2023)
TABLE 17. Key drivers and restraints
TABLE 18. Technology adoption trends
TABLE 19. Pricing analysis and forecast
TABLE 20. Distribution channel performance analysis
List of Figures
FIGURE 1. Global Equine Healthcare research methodology
FIGURE 2. Market estimation techniques
FIGURE 3. Global market size estimates & forecast methods
FIGURE 4. Key trends in Equine Healthcare market, 2023
FIGURE 5. Growth prospects, 2022–2032
FIGURE 6. Porter’s Five Forces analysis
FIGURE 7. PESTEL analysis
FIGURE 8. Value chain analysis
FIGURE 9. Market share by Product, 2023
FIGURE 10. Market share by Indication, 2023
FIGURE 11. Market share by Activity, 2023
FIGURE 12. Market share by Distribution Channel, 2023
FIGURE 13. Regional snapshot, 2022 & 2032
FIGURE 14. North America market, 2022 & 2032
FIGURE 15. Europe market, 2022 & 2032
FIGURE 16. Asia Pacific market, 2022 & 2032
FIGURE 17. Latin America market, 2022 & 2032
FIGURE 18. Middle East & Africa market, 2022 & 2032
FIGURE 19. Company market share analysis (2023)
FIGURE 20. Pricing forecast trend, 2022–2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us